temozolomide has been researched along with alvocidib in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Adachi, K; Hayashi, T; Hirose, Y; Ohba, S | 1 |
Chen, Z; Liang, H; Sun, L | 1 |
4 other study(ies) available for temozolomide and alvocidib
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
The Cdk inhibitor flavopiridol enhances temozolomide-induced cytotoxicity in human glioma cells.
Topics: Animals; Antineoplastic Agents, Alkylating; Brain Neoplasms; Cell Cycle; Colony-Forming Units Assay; Comet Assay; Cyclin-Dependent Kinases; Dacarbazine; Drug Synergism; Female; Flavonoids; Fluorescent Antibody Technique; Glioma; Humans; Immunoblotting; Mice; Mice, Inbred BALB C; Piperidines; Protein Kinase Inhibitors; Temozolomide; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2013 |
Inhibition of cyclin E1 overcomes temozolomide resistance in glioblastoma by Mcl-1 degradation.
Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Brain Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cyclin E; Drug Resistance, Neoplasm; Female; Flavonoids; Glioblastoma; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Transplantation; Oncogene Proteins; Piperidines; Protein Kinase Inhibitors; Temozolomide; Transplantation, Heterologous | 2019 |